Cargando…

Glucagon‐like peptide‐1 receptor agonist inhibits aeroallergen‐induced activation of ILC2 and neutrophilic airway inflammation in obese mice

BACKGROUND: Obesity is a risk factor for the development of asthma. However, pharmacologic therapeutic strategies that specifically target obese asthmatics have not been identified. We hypothesize that glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) treatment inhibits aeroallergen‐induced early i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toki, Shinji, Newcomb, Dawn C., Printz, Richard L., Cahill, Katherine N., Boyd, Kelli L., Niswender, Kevin D., Peebles, R. Stokes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597133/ https://www.ncbi.nlm.nih.gov/pubmed/33955007 http://dx.doi.org/10.1111/all.14879

Ejemplares similares

Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma
por: Toki, Shinji, et al.
Publicado: (2023)

TSLP and IL‐33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type‐2 airway inflammation
por: Toki, Shinji, et al.
Publicado: (2020)

The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation
por: Toki, Shinji, et al.
Publicado: (2016)

Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation
por: Cahill, Katherine N., et al.
Publicado: (2022)

Neural regulation of ILC2s in allergic airway inflammation
por: Thomas, Christopher M., et al.
Publicado: (2023)

ILC2 the Rescue?
por: Peebles, R. Stokes
Publicado: (2020)

Prostaglandin I2 inhibits IL-33-induced IL-5 and IL-13 production by human type 2 innate lymphoid cells
por: Zhou, Weisong, et al.
Publicado: (2015)

Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity
por: Galle-Treger, Lauriane, et al.
Publicado: (2016)

Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
por: Stier, Matthew T., et al.
Publicado: (2016)

Role of SHIP-1 in the Adaptive Immune Responses to Aeroallergen in the Airway
por: Roongapinun, Sukit, et al.
Publicado: (2010)

Eosinophilic Airway Inflammation and Airway Hyperresponsiveness According to Aeroallergen Sensitization Pattern in Patients With Lower Airway Symptoms
por: Jo, Eun-Jung, et al.
Publicado: (2014)

Airway Epithelium Interactions with Aeroallergens: Role of Secreted Cytokines and Chemokines in Innate Immunity
por: Gandhi, Vivek D., et al.
Publicado: (2015)

Association of Sensitization to Different Aeroallergens With Airway Function and Nasal Patency in Urban Children
por: Lee, Shinhae, et al.
Publicado: (2019)

Fungal Aeroallergen Sensitization Patterns among Airway-Allergic Patients in Zagazig, Egypt
por: Mokhtar, Ghada A., et al.
Publicado: (2023)

Cytokines in sensitization to aeroallergens
por: Albrecht, M., et al.
Publicado: (2018)

PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
por: Helou, Doumet Georges, et al.
Publicado: (2020)

Chronic Respiratory Aeroallergen Exposure in Mice Induces Epithelial-Mesenchymal Transition in the Large Airways
por: Johnson, Jill R., et al.
Publicado: (2011)

Editorial: Climate Change and Aeroallergens
por: Damialis, Athanasios, et al.
Publicado: (2021)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Triclosan‐induced alteration of gut microbiome and aggravation of asthmatic airway response in aeroallergen‐sensitized mice
por: Hirota, Ryoji, et al.
Publicado: (2019)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

How glucagon-like peptide 1 receptor agonists work
por: Andreasen, Christine Rode, et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
por: Baggio, Laurie L., et al.
Publicado: (2020)

Effects of exendin-4, a glucagon like peptide-1 receptor agonist, on neutrophil count and inflammatory cytokines in a rat model of endotoxemia
por: Yanay, Ofer, et al.
Publicado: (2015)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Regional diagnostic panels for aeroallergens in Canada
por: Young, Joshua, et al.
Publicado: (2014)

Seasonal Variation in Skin Sensitivity to Aeroallergens
por: Choi, Inseon S., et al.
Publicado: (2013)

Hypersensitivity to Aeroallergens in Patients with Nasobronchial Allergy
por: Balaban, Jagoda, et al.
Publicado: (2014)

Barriers to accessing aeroallergen immunotherapy in paediatrics
por: Trayer, James, et al.
Publicado: (2022)

Fungal Aeroallergens—The Impact of Climate Change
por: Sztandera-Tymoczek, Monika, et al.
Publicado: (2023)

Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses
por: Lotz, Matthew T., et al.
Publicado: (2012)

A Selective α7 Nicotinic Acetylcholine Receptor Agonist, PNU-282987, Attenuates ILC2s Activation and Alternaria-Induced Airway Inflammation
por: Yuan, Fang, et al.
Publicado: (2021)

Aeroallergens, Allergic Disease, and Climate Change: Impacts and Adaptation
por: Reid, Colleen E., et al.
Publicado: (2009)

Airway Mucus Dysfunction in COVID-19
por: Dickey, Burton F., et al.
Publicado: (2022)

Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists
por: Zhang, Yu-Juan, et al.
Publicado: (2013)

Glucagon‐like peptide‐1 receptor agonists and their effects on weight reduction
por: Shin, Shyi‐Jang
Publicado: (2012)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

The potential of glucagon-like peptide-1 receptor agonists in heart failure
por: Kreiner, Frederik Flindt, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
por: Delgado, A., et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
por: Wojtara, Magda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l9651d2cq9a7acfovpvgfn4rq9